Comparative study of images with pathology: Superparamagnetic iron oxide-enhanced magnetic resonance image (MRI) of splenic VX2 tumor in rats | |
Alternative Title | Comparative Study of Images with Pathology: Superparamagnetic Iron Oxide-enhanced Magnetic Resonance Image (MRI) of Splenic VX2 Tumor in Rats |
Yang Hongyan1; Xu Yikai2; Wu Yuankui2; Liu Wenyuan3; Lue Guoshi2; Cao Guohong2 | |
2008 | |
Source Publication | CHINESE JOURNAL OF CANCER RESEARCH
![]() |
ISSN | 1000-9604 |
Volume | 20Issue:1Pages:26-32 |
Abstract | Objective: To establish a rodent model of VX2 tumor of the spleen, to analyze relationship between the change of the signal intensity on superparamagnetic iron oxide enhanced magnetic resonance image (MRI) and pathologic change to evaluate the ability of superparamagnetic iron oxide enhanced MRI for detection of splenic metastases. Methods: 8 rodent models of VX2 tumor of spleen were established successfully. The images were obtained before and after administration of superparamagnetic iron oxide. T1-weighted spin-echo (SE) pulse sequence with a repetition time (TR) of 450 msec, and echo time (TE) of 12 msec (TR/TE= 450/12) was used. The imaging parameters of T2-weighted SE pulse sequence were as follows: TR/TE= 4000/128. Results: On plain MR scanning T1-weighted splenic VX2 tumor showed hypointensity or isointensity which approximated to the SI of splenic parenchyma. Therefore all lesions were not displayed clearly. On superparamagnetic iron oxide enhancement T2WI sequence the SI of splenic parenchyma decreased obviously with percentage of signal intensity loss (PSIL) of 55.04%, But the SI of tumor was not evidently changed with PSIL of 0.87%. Nevertheless the SNR of normal splenic parenchyma around the lesions had obvious difference (P< 0.001) comparatively. Therefore the contrast between tumor and spleen increased, and tumor displayed more clearly. Moreover the contrast-to-noise (CNR) between VX2 tumor and splenic parenchyma had an evident difference before and after admininstration of superparamagnetic iron oxide (P< 0.001). Conclusion: On superparamagnetic iron oxide enhancement T1WI sequence the contrast of tumor-to-spleen is poor. Therefore it is not sensitive to characterize the lesions in spleen. On superparamagnetic iron oxide enhanced T2WI the contrast degree of lesions increases obviously. Consequently, superparamagnetic iron oxide -enhanced T2WI MRI scanning can improve the rate of detection and characterization for lesions of spleen. |
Other Abstract | Objective: To establish a rodent model of VX2 tumor of the spleen, to analyze relationship between the change of the signal intensity on superparamagnetic iron oxide enhanced magnetic resonance image (MRI) and pathologic change to evaluate the ability of superparamagnetic iron oxide enhanced MRI for detection of splenic metastases. Methods: 8 rodent models of VX2 tumor of spleen were established successfully. The images were obtained before and after administration of superparamagnetic iron oxide. T1-weighted spin-echo (SE) pulse sequence with a repetition time (TR) of 450 msec, and echo time (TE) of 12 msec (TR/TE=450/12) was used. The imaging parameters of T2-weighted SE pulse sequence were as follows: TR/TE=4000/128. Results: On plain MR scanning T1-weighted splenic VX2 tumor showed hypointensity or isointensity which approximated to the SI of splenic parenchyma. Therefore all lesions were not displayed clearly. On superparamagnetic iron oxide enhancement T2WI sequence the SI of splenic parenchyma decreased obviously with percentage of signal intensity loss (PSIL) of 55.04%, But the SI of tumor was not evidently changed with PSIL of 0.87%. Nevertheless the SNR of normal splenic parenchyma around the lesions had obvious difference (P〈0.001) comparatively. Therefore the contrast between tumor and spleen increased, and tumor displayed more clearly. Moreover the contrast-to-noise (CNR) between VX2 tumor and splenic parenchyma had an evident difference before and after admininstration of superparamagnetic iron oxide (P〈0.001). Conclusion: On superparamagnetic iron oxide enhancement T1WI sequence the contrast of tumor-to-spleen is poor. Therefore it is not sensitive to characterize the lesions in spleen. On superparamagnetic iron oxide enhanced T2WI the contrast degree of lesions increases obviously. Consequently, superparamagnetic iron oxide -enhanced T2WI MRI scanning can improve the rate of detection and characterization for lesions of spleen. |
Keyword | LIVER METASTASES RESOVIST SPLEEN spleen tumor superparamagnetic iron oxide magnetic resonance imaging pathology |
Indexed By | CSCD |
Language | 英语 |
CSCD ID | CSCD:3251546 |
Citation statistics | |
Document Type | 期刊论文 |
Identifier | http://ir.imr.ac.cn/handle/321006/153084 |
Collection | 中国科学院金属研究所 |
Affiliation | 1.Chengdu Army Gen Hosp, Department Med Imaging, Chengdu 610083, Peoples R China 2.中国科学院广州地球化学研究所 3.中国科学院金属研究所 |
Recommended Citation GB/T 7714 | Yang Hongyan,Xu Yikai,Wu Yuankui,et al. Comparative study of images with pathology: Superparamagnetic iron oxide-enhanced magnetic resonance image (MRI) of splenic VX2 tumor in rats[J]. CHINESE JOURNAL OF CANCER RESEARCH,2008,20(1):26-32. |
APA | Yang Hongyan,Xu Yikai,Wu Yuankui,Liu Wenyuan,Lue Guoshi,&Cao Guohong.(2008).Comparative study of images with pathology: Superparamagnetic iron oxide-enhanced magnetic resonance image (MRI) of splenic VX2 tumor in rats.CHINESE JOURNAL OF CANCER RESEARCH,20(1),26-32. |
MLA | Yang Hongyan,et al."Comparative study of images with pathology: Superparamagnetic iron oxide-enhanced magnetic resonance image (MRI) of splenic VX2 tumor in rats".CHINESE JOURNAL OF CANCER RESEARCH 20.1(2008):26-32. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment